Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 4/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | MPI | P34949 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20258262 | 0.82 | CYP3A4 (0.37) | NPC1RAB9ACYP3A4ADRA2ATDP1 | |
| SCHEMBL11693234 | 0.79 | NPC1 (0.72) | NPC1RAB9ACYP3A4ADRA2ATDP1 | |
| SCHEMBL1637262 | 0.79 | RAB9A (0.54) | NPC1RAB9ACYP3A4ADRA2ATDP1 | |
| SCHEMBL11693231 | 0.79 | NPC1 (0.72) | NPC1RAB9ACYP3A4ADRA2ATDP1 | |
| SCHEMBL14518104 | 0.78 | NPC1 (0.48) | NPC1RAB9ACYP3A4ADRA2ATDP1 | |
| SCHEMBL7050721 | 0.77 | NPC1 (0.52) | NPC1RAB9ACYP3A4ADRA2ATDP1 | |
| SCHEMBL22919543 | 0.76 | SIGMAR1 (0.47) | NPC1RAB9ACYP3A4ADRA2AMAPT | |
| SCHEMBL14679678 | 0.76 | ALDH1A1 (0.52) | NPC1RAB9ACYP3A4LMNAMAPT | |
| SCHEMBL21872427 | 0.76 | NFE2L2 (0.36) | NPC1RAB9ACYP3A4ADRA2ATDP1 | |
| SCHEMBL22006154 | 0.76 | CYP3A4 (0.52) | NPC1RAB9ACYP3A4ADRA2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230272275-A1 | PHOSPHOROUS HOST MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2023-08-31 | — | — | US | disclosed |
| US-11527728-B2 | Organic electroluminescent compounds and organic electroluminescent device comprising the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. | 2022-12-13 | — | — | US | disclosed |
| EP-3888691-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LIKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | Hangzhou Dac Biotech Co., Ltd. (CN) | 2021-10-06 | — | — | EP | disclosed |
| EP-3636726-B1 | MULTI-COMPONENT HOST MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM & HAAS ELECT MATERIALS KOREA LTD (KR) | 2021-07-14 | — | — | EP | disclosed |
| US-20200106027-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2020-04-02 | — | — | US | disclosed |
| WO-2020006722-A1 | CROSS-LINKED PYRROLOBENZODIAZEPINE DIMER (PBD) DERIVATIVE AND ITS CONJUGATES | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2020-01-09 | — | — | WO | disclosed |
| US-20190288222-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2019-09-19 | — | — | US | disclosed |
| US-20190221758-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM & HAAS ELECT MATERIALS KOREA LTD (KR) | 2019-07-18 | — | — | US | disclosed |
| US-20180182973-A1 | A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2018-06-28 | — | — | US | disclosed |
| WO-2018066812-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2018-04-12 | — | — | WO | disclosed |
| US-20170158673-A1 | QUINAZOLINONE DERIVATIVES AS PARP INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2017-06-08 | — | — | US | disclosed |
| US-9522905-B2 | Quinazolinone derivatives as PARP inhibitors | JANSSEN PHARMACEUTICA NV (BE) | 2016-12-20 | — | — | US | disclosed |
| EP-1960411-B1 | HALOGEN SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2016-08-31 | — | — | EP | disclosed |
| EP-1313435-B2 | BLEACHING COMPOSITION FOR DYED KERATINOUS FIBRES | ORÉAL L (FR) | 2016-08-10 | — | — | EP | disclosed |
| US-20140080835-A1 | QUINAZOLINONE DERIVATIVES AS PARP INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2014-03-20 | — | — | US | disclosed |
| US-8623872-B2 | Quinazolinone derivatives as PARP inhibitors | JANSSEN PHARMACEUTICA, NV (BE) | 2014-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190288222-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ICOSLG, ELAVL1, SOD1 | NPC1 3557/4885RAB9A 1328/4885CYP3A4 1740/4885 |
| US-20230272275-A1 | PHOSPHOROUS HOST MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | PPA1, ENPP1, ITPA | NPC1 3564/4885RAB9A 2994/4885CYP3A4 4180/4885 |
| US-11527728-B2 | Organic electroluminescent compounds and organic electroluminescent device comprising the same | VDAC1, VDAC2, VAPA | NPC1 3003/4885RAB9A 1034/4885CYP3A4 3298/4885 |
| US-20140080835-A1 | QUINAZOLINONE DERIVATIVES AS PARP INHIBITORS | PARP1, PARP3, PARP2 | NPC1 3239/4885RAB9A 2216/4885CYP3A4 875/4885 |
| US-20200106027-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | VDAC1, VDAC2, VAPA | NPC1 3003/4885RAB9A 1034/4885CYP3A4 3298/4885 |
| US-20170158673-A1 | QUINAZOLINONE DERIVATIVES AS PARP INHIBITORS | PARP1, PARP3, PARP2 | NPC1 3239/4885RAB9A 2216/4885CYP3A4 875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.